Company Response

Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Gilead Sciences has not responded to

Prices of AIDS medicines in developing countries continue to be a concern

Story 28 Jun 2005

Timeline

Prices of AIDS medicines in developing countries continue to be a concern

Date:

28 Jun 2005

Content Type:

Article
Gilead Sciences did not respond to: Médecins Sans Frontières says prices of essential new AIDS drugs in developing countries are too high.

Date:

28 Jun 2005

Content Type:

Company Response

View full story